Telix Pharmaceuticals TLX
$8.37 −$0.34 (-3.90%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.37 0.00%
Open$8.66
Prev close$8.71
Day range$8.37 – $8.70
Volume269.4K
Market cap$2.84B
P/E (TTM)86.3
Dividend yield–
Earnings
Average move on report day±7.1%last 4 reports
Closed higher4 of 4100% of the time
Best reaction+14.6%
Worst reaction1.3%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q2 | 19 Aug 2026 | After Market | – | +2.48% | – |
| 2025/Q4 | 19 Feb 2026 | After Market | – | +14.61% | – |
| 2025/Q2 | 20 Aug 2025 | After Market | – | +10.21% | – |
| 2024/Q4 | 19 Feb 2025 | After Market | – | +1.28% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2025/FY
By business line
By region
Fundamentals
Latest reported quarter: ANNUAL, ended Dec 2025
Revenue$803.79M+55.6% YoY
Operating profit$18.05M-67.5% YoY
Net profit-$7.13M-121.2% YoY
Diluted EPS-$0.02-121.6% YoY
Free cash flow-$15.08M-1,487.3% YoY
Profitability & balance sheet
Gross margin53.7%
Operating margin5.3%
Net margin3.8%
Return on equity7.4%
Return on assets2.6%
Return on invested capital6.4%
Current ratio2.01
Liabilities / assets64.2%
Cash & investments$251.91M
Total debt$575.95M
Net cash (debt)-$324.04M
No comments yet — be the first to weigh in on TLX.
Sign in to join the discussion.